Huajin Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biotech startup Arnatar raises $50m Series A round to build China presence

Founded in 2022, Arnatar specialises in antisense drug discovery and development.

United statesSan diegoXuehai liangYanfeng wangTransfar groupMerck coValliance capitalIonis pharmaceuticalsLegend holdingsArnatar therapeuticsEight roadsHuajin capitalGaorong capitalJifeng venturesNew alliance capitalYijing capital

China Digest: NGGT, OptoMedic raise funding

China Digest: NGGT, OptoMedic raise funding
dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.

Shanghai industrial investment holdingsDrug administrationChina construction bankShanghai healthcare capitalHuajin capitalNext generation gene therapeuticsShanghai industrial investmentBeijing wedo capital managementNorthern light venture capitalInvestigational new drugGuangdong optomedic technologiesEquity investment managementZhuhai huajinGuosen capitalBefor capitalPrimavera capital

China Digest: Eccogene, UDS, Emposat snap funding

China Digest: Eccogene, UDS, Emposat snap funding
dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.

Shang qiChina generalTaicanggang hongrun private equity fund managementTechnology investmentValliance capitalNew alliance capitalZhongguancun science parkZhangjiang healthcare ventureRockbleu capitalYufu investmentHuajin capitalElikon ventureDelos capitalOriza seed capitalQingsong capitalShanghai zhangjiang science

Eccogene Raises CNY 180 Million in Series B Equity Financing, Propelling its Pipeline of Treatments for Metabolic Diseases

/PRNewswire/ Eccogene Inc., a clinical-stage biotechnology company developing innovative therapeutic solutions for metabolic diseases, today announced a CNY.

United statesJingye zhouEccogene incValliance capitalNew alliance capitalZhangjiang healthcare ventureRockbleu capitalYufu investmentHuajin capitalElikon ventureDelos capitalOriza seed capitalChief executive officer

Eccogene Raises CNY 180M in Series B Equity Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Jingye zhouValliance capitalSeriesb equityNew alliance capitalZhangjiang healthcare ventureRockbleu capitalYufu investmentHuajin capitalElikon ventureDelos capitalOriza seed capital